SHR-1701；BP102

DRUG2 trials

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Conditions

Advanced Solid TumorsAdvanced or Metastatic Non-squamous Non-small Cell Lung Cancer

Phase 1

Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

CompletedNCT04856774

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced Solid Tumors

Start: 2021-06-01End: 2024-03-30Updated: 2024-06-27

Phase 2

Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer

Start: 2021-08-30End: 2022-08-30Target: 71Updated: 2021-07-23